Compare FMC Corp (FMC) vs Select Medical Holdings Corporation (SEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FMC Corp vs Select Medical Holdings Corporation — how do they compare? FMC Corp trades at $11.58 (market cap $1.36B), while Select Medical Holdings Corporation trades at $16.51 (market cap $2.05B). The key difference: Select Medical Holdings Corporation is the larger of the two by market cap, and FMC Corp pays the higher dividend (2.95%). Which is the better fit depends on your goals.
| FMC | SEM | |
|---|---|---|
Market Cap | $1.36B | $2.05B |
Sector | Basic Materials | Health |
52-Week High | $43.90 | $16.66 |
52-Week Low | $10.72 | $11.77 |
Enterprise Value | $5.50B | $5.01B |
Dividend Yield | 2.95% | 1.51% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FMC Corporation (FMC) trades at $10.72, down 1.74% on the day, reflecting ongoing challenges despite recent strategic moves. The stock shows a bearish technical trend with oversold RSI signals, while fundamentals reveal significant pressure with a net income margin of -72.93% and negative ROE of -80.78% for 2025. Recent developments include a $400 million minority investment from Tessenderlo Group and regulatory submission for new herbicide rimisoxafen, providing some operational support amid financial restructuring.
The outlook remains cautious with analyst consensus leaning neutral (50% Hold) despite a $16 price target suggesting 49% upside. Key risks include persistent revenue declines, high debt levels, and negative cash flow from operations. Investment opportunity exists if new product approvals and debt reduction efforts successfully stabilize profitability, but current financial metrics indicate substantial execution risk near term.
Select Medical Holdings Corporation (SEM) trades at $16.51, unchanged on the day, with a mixed technical picture showing bullish oscillators but bearish moving averages. Recent earnings show volatility with Q3 2025 beating estimates but Q1 2026 missing, while valuation ratios like P/E of 15.43 and P/S of 0.36 suggest moderate pricing. The company announced a $0.06 dividend for H1 2026, but news highlights its acquisition completion by a consortium led by Robert A. Ortenzio in June 2026, with legal investigations into the fairness of the $16.50 per share deal.
The outlook is clouded by acquisition-related uncertainties and legal scrutiny, posing risks to shareholder value. Analyst consensus leans neutral with 57.15% hold ratings, reflecting cautious sentiment amid the takeover. Investors should weigh the stable fundamentals against potential dilution or litigation outcomes, with the stock's near-term direction tied to resolution of these corporate actions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About FMC Corp
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →About Select Medical Holdings Corporation
Select Medical Holdings Corporation is one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. The company's services focus on treating patients with serious illnesses, injuries, and post-acute care needs. SEM provides specialized care across various settings, aiming to help patients recover and return home.
Read more on SEM →
